Aktive Positionen von Sophia Park
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TURG POIN | Direktor/Vorstandsmitglied | 17.08.2022 | - |
X-Body, Inc.
 X-Body, Inc. BiotechnologyHealth Technology X-BODY, Inc. provides biotechnological research services. The company was founded on April 9, 2009 and is headquartered in Waltham, MA. | Direktor/Vorstandsmitglied | - | - |
| Präsident | - | - |
Karriereverlauf von Sophia Park
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Director/Board Member | 2 |
| President | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
X-Body, Inc.
X-Body, Inc. BiotechnologyHealth Technology X-BODY, Inc. provides biotechnological research services. The company was founded on April 9, 2009 and is headquartered in Waltham, MA. | Health Technology |
- Börse
- Insiders
- Sophia Park
- Erfahrung
